These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. ATRA alters humoral responses associated with amelioration of EAMG symptoms by balancing Tfh/Tfr helper cell profiles. Xie X; Mu L; Yao X; Li N; Sun B; Li Y; Zhan X; Wang X; Kang X; Wang J; Liu Y; Zhang Y; Wang G; Wang D; Liu X; Kong Q; Li H Clin Immunol; 2013 Aug; 148(2):162-76. PubMed ID: 23773919 [TBL] [Abstract][Full Text] [Related]
7. Experimental models of myasthenia gravis: lessons in autoimmunity and progress toward better forms of treatment. Pachner AR Yale J Biol Med; 1987; 60(2):169-77. PubMed ID: 3495075 [TBL] [Abstract][Full Text] [Related]
9. T cells and cytokines in the pathogenesis of acquired myasthenia gravis. Milani M; Ostlie N; Wang W; Conti-Fine BM Ann N Y Acad Sci; 2003 Sep; 998():284-307. PubMed ID: 14592887 [TBL] [Abstract][Full Text] [Related]
10. Standardization of the experimental autoimmune myasthenia gravis (EAMG) model by immunization of rats with Torpedo californica acetylcholine receptors--Recommendations for methods and experimental designs. Losen M; Martinez-Martinez P; Molenaar PC; Lazaridis K; Tzartos S; Brenner T; Duan RS; Luo J; Lindstrom J; Kusner L Exp Neurol; 2015 Aug; 270():18-28. PubMed ID: 25796590 [TBL] [Abstract][Full Text] [Related]
11. Role for interferon-gamma in rat strains with different susceptibility to experimental autoimmune myasthenia gravis. Wang HB; Shi FD; Li H; van der Meide PH; Ljunggren HG; Link H Clin Immunol; 2000 May; 95(2):156-62. PubMed ID: 10779409 [TBL] [Abstract][Full Text] [Related]
12. Introducing Autoimmunity at the Synapse by a Novel Animal Model of Experimental Autoimmune Myasthenia Gravis. Wang J; Xiao Y; Zhang K; Luo B; Shen C Neuroscience; 2018 Mar; 374():264-270. PubMed ID: 29421431 [TBL] [Abstract][Full Text] [Related]
13. Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice. Balasa B; Deng C; Lee J; Bradley LM; Dalton DK; Christadoss P; Sarvetnick N J Exp Med; 1997 Aug; 186(3):385-91. PubMed ID: 9236190 [TBL] [Abstract][Full Text] [Related]
14. Novel animal models of acetylcholine receptor antibody-related myasthenia gravis. Tüzün E; Allman W; Ulusoy C; Yang H; Christadoss P Ann N Y Acad Sci; 2012 Dec; 1274():133-9. PubMed ID: 23252908 [TBL] [Abstract][Full Text] [Related]
15. Animal models of myasthenia gravis. Christadoss P; Poussin M; Deng C Clin Immunol; 2000 Feb; 94(2):75-87. PubMed ID: 10637092 [TBL] [Abstract][Full Text] [Related]
16. Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental automimmune myasthenia gravis. Lindstrom JM; Einarson BL; Lennon VA; Seybold ME J Exp Med; 1976 Sep; 144(3):726-38. PubMed ID: 182896 [TBL] [Abstract][Full Text] [Related]
17. Age-related resistance to experimental autoimmune myasthenia gravis in rats. Graus YM; Verschuuren JJ; Spaans F; Jennekens F; van Breda Vriesman PJ; De Baets MH J Immunol; 1993 May; 150(9):4093-103. PubMed ID: 8386206 [TBL] [Abstract][Full Text] [Related]